9,170 Shares in U.S. Physical Therapy, Inc. (NYSE:USPH) Purchased by Semanteon Capital Management LP

Semanteon Capital Management LP purchased a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 9,170 shares of the company's stock, valued at approximately $776,000. Semanteon Capital Management LP owned about 0.06% of U.S. Physical Therapy as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Silvercrest Asset Management Group LLC purchased a new position in U.S. Physical Therapy in the first quarter worth approximately $8,158,000. Harbor Capital Advisors Inc. grew its position in U.S. Physical Therapy by 292.5% in the second quarter. Harbor Capital Advisors Inc. now owns 7,584 shares of the company's stock worth $701,000 after acquiring an additional 5,652 shares during the period. Norden Group LLC boosted its position in shares of U.S. Physical Therapy by 1,841.6% during the first quarter. Norden Group LLC now owns 63,938 shares of the company's stock worth $7,217,000 after buying an additional 60,645 shares during the period. Vanguard Group Inc. boosted its position in shares of U.S. Physical Therapy by 1.0% during the first quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company's stock worth $121,065,000 after buying an additional 10,175 shares during the period. Finally, CANADA LIFE ASSURANCE Co boosted its position in shares of U.S. Physical Therapy by 5.8% during the first quarter. CANADA LIFE ASSURANCE Co now owns 12,642 shares of the company's stock worth $1,423,000 after buying an additional 696 shares during the period.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin purchased 2,000 shares of the business's stock in a transaction on Tuesday, September 3rd. The shares were bought at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the purchase, the director now directly owns 18,904 shares in the company, valued at approximately $1,627,445.36. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the firm's stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the sale, the chief operating officer now directly owns 7,038 shares in the company, valued at $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kathleen A. Gilmartin purchased 2,000 shares of the business's stock in a transaction on Tuesday, September 3rd. The stock was acquired at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the purchase, the director now owns 18,904 shares of the company's stock, valued at $1,627,445.36. This represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.70% of the stock is currently owned by company insiders.

U.S. Physical Therapy Stock Up 1.1 %

NYSE:USPH traded up $0.91 during midday trading on Monday, reaching $81.68. The company had a trading volume of 65,316 shares, compared to its average volume of 88,950. The firm has a market capitalization of $1.23 billion, a price-to-earnings ratio of 66.41, a PEG ratio of 3.83 and a beta of 1.39. The stock's fifty day simple moving average is $83.10 and its 200-day simple moving average is $92.25. U.S. Physical Therapy, Inc. has a 12-month low of $76.18 and a 12-month high of $113.63. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.28.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.82 by ($0.09). The company had revenue of $167.19 million during the quarter, compared to analysts' expectations of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The company's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter last year, the business posted $0.76 earnings per share. On average, sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.58 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 13th. Investors of record on Friday, August 23rd were issued a $0.44 dividend. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a yield of 2.15%. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 143.09%.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Barrington Research restated an "outperform" rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research report on Wednesday, October 9th. Bank of America restated a "neutral" rating and set a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. Finally, StockNews.com upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Wednesday, August 21st.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.